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Background: The population of obese patients is progressively growing and bariatric operations are becoming
increasingly common. Morbidly obese patients require special anesthetic care and are often considered to be
difficult to ventilate and intubate. The VivaSight™ Single Lumen tube is an endotracheal tube with a camera
embedded in its tip. The view from the tip appears continuously on a monitor in the anesthesiologist's vicinity. The
aim of this study was to assess the VivaSight™ in comparison with conventional endotracheal tube as an aid in the
intubation and surveillance of tube position during surgery of obese patients.
Methods: This is a prospective study of 72 adult obese patients who underwent laparoscopic sleeve gastrectomy. The
patients were randomly assigned to be intubated by either the VivaSight™ (40 patients, test group) or a conventional
endotracheal tube (32 patients, control group). Data on the patients, the pre-operative airway evaluation, the endotracheal
intubation and the post-operative outcome were collected and compared.
Results: The Mallampati scores were significantly higher in the test group than in the control group. Endotracheal
intubation took 29 ± 10 and 24 ± 8 seconds using the VivaSight™ and a conventional tube respectively (p = 0.02).
Three of the patients in the control group, while none of those in the test group, had soft tissue injury (p < 0.05).
Conclusion: We found the VivaSight™ SL to be helpful in the endotracheal intubation and continuous
surveillance of tube position in morbidly obese patients undergoing laparoscopic sleeve gastrectomy.
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The number of obese patients who require bariatric and
non-bariatric surgery is progressively increasing [1-3].
The obese patient presents numerous problems and chal-
lenges to the surgeon and anesthesiologist [4]. Morbidly
obese patients are often difficult to ventilate and difficult
to intubate [5,6]. These difficulties may be aggravated in
the obese patient by rapidly occurring hypoxemia, due to
decreased functional residual capacity and low oxygen re-
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unless otherwise stated.morbidity and mortality [7]. Several solutions have been
suggested and tried for managing the obese patient’s air-
ways and ventilation during anesthesia [8-12].
The VivaSight™ Single Lumen (SL) endotracheal tube
(ETT) (ETView Ltd., Misgav 20174 Israel) is a single-use
ETT with an integrated high-resolution imaging camera
embedded in the tube's tip (Figure 1) [13,14]. The exter-
nal structure and dimensions of the VivaSight™ SL ETT
are similar to those of the conventional ETT, and the de-
vice is available in sizes 7.0, 7.5 and 8.0 mm. The view
from the tube tip appears continuously on a portable
monitor (Figures 2,3) in the anesthesiologist's vicinity.
According to the manufacturer, the appliance (a) facili-
tates fast and efficient intubation, (b) provides visual as-
surance during intubation, and (c) permits continuous,
real-time images of tube position, which can be viewedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The VivaSight™ Single Lumen endotracheal tube with
a camera embedded in its tip.
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(LCD) monitor. The VivaSight™ SL has United States
Food and Drug Administration approval and the CE
marking.
Laparoscopic sleeve gastrectomy is a bariatric procedure
in which a considerable longitudinal part of the stomach
is removed and the remaining stomach is shaped into a
tube or "sleeve". During laparoscopic sleeve gastrectomy,
the ETT position may change due to pneumoperitoneum
and the patient's position [15,16]. Confirmation of ETT
position by auscultation is especially difficult in obese pa-
tients and approaching the patient or the ETT is not al-
ways easy during the surgery.
Our hypothesis was that the VivaSight™ SL ETT could
be helpful in tracheal intubation and possibly will assist
in the surveillance of tube position during laparoscopic
sleeve gastrectomy because it facilitates visualization of
the patient's airway during and after endotrachealFigure 2 A clear view of the patient's carina is seen on the
screen of the VivaSight™ monitor.intubation. The study's specific goal was to assess the
clinical performance of VivaSight™ SL in comparison
with conventional ETT. Primary outcome was intubation
time; other features that were tested: direct laryngo-
scopic view, number of attempts to accomplish intub-
ation and post-operative consequences, such as soft
tissue injury. By studying the technical features of its use
one can appreciate whether this novel device will add in
the management of airway during operations of mor-
bidly obese patients.
Methods
This was a prospective study of adult patients who under-
went elective laparoscopic sleeve gastrectomy in our
hospital. The study was approved by the local Ethics Com-
mittee (Rambam Health Care Campus Ethics Committee;
approval number 0181-09-RMB) and all patients signed
an informed consent. Permission to reproduce the images
after endotracheal intubation with the VivaSight™ SL ETT
in Figures 2 and 3 was obtained from the patient.
The patients were randomly assigned into two groups:
a control group of 32 patients which were intubated
with a conventional ETT and a test group of 40 patients
who were intubated with the VivaSight™ SL ETT. The
sample size of the test group was limited by the number
of VivaSight™ tubes that were supplied by the appliance's
manufacturer. Exclusion criteria were: American Society
of Anesthesiologists (ASA) class ≥4, pregnancy, patients
who required rapid sequence induction and patients
with known tracheal pathology.
All patients in both groups received standard identical
care before and during the operation, with the only differ-
ence set to be the ETT type used. Each patient was admit-
ted to hospital one day before the scheduled surgery, was
examined by a surgeon and an anesthesiologist, who alsoFigure 3 The patient after endotracheal intubation with the
VivaSight™ SL endotracheal tube. The patient's carina is seen on
the screen of the VivaSight™ monitor.
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patient was pre-medicated with oral metoclopramide
(10 mg) and diazepam (10 mg), which is our hospital's
routine pre-medication in all the patients undergoing sur-
gery. In the operating room, the patient was monitored
with non-invasive blood pressure, electrocardiogram and
pulse-oximeter, and a peripheral intravenous (IV) access
was established. Pre-oxygenation was achieved using a
face mask which delivered oxygen at 10 liters/min for
five minutes before tracheal intubation. General anesthesia
in each patient was induced by an intravenous bolus in-
jection of propofol (2–3 mg kg−1) and fentanyl (0.001-
0.002 mg kg−1), followed by vecuronium (0.08 mg kg−1).
In cases where mask ventilation was difficult, as assessed
by the intubating anesthesiologist after the administration
of propofol, based on the effort used in ventilation with
the bag and on the capnography, vecuronium was not
administered and awake fiberoptic intubation was per-
formed; the patient was removed from the study.
Anesthesia in all patients was maintained by sevoflur-
ane in a mixture of oxygen and air and a continuous IV
infusion of remifentanil. Endotracheal intubation was
performed by an experienced anesthesiologist (MB or
AB). Each anesthesiologist was trained in the use of the
VivaSight™ prior to the study on a manikin with the
manufacturer's instructor help. The device was then
used on at least a dozen patients, who were not in-
cluded in the study. Intubation with the tested device
or with conventional ETT was performed when hypnosis
and muscle relaxation were fully achieved. Intubation was
done using a standard 7.5 mm ETT in the control group
and a 7.5 mm VivaSight™ SL in the test group. The Viva-
Sight™ ETT was connected to a 3.6"(screen size) monitor
and the tube was fixed with adhesive tape and a cotton
band when a clear picture of the patient's carina was seen
on the monitor's screen (Figure 3). ETT fixation was iden-
tical in the control group. Following tube fixation, the pa-
tient was placed in a sitting position and prepared for
surgery.
During the surgery, the patient's carina was continuously
visualized on the monitor's screen by the anesthesiologist
and ETT position was recorded every 5 minutes. Tube
movement within 1 cm was recorded, as was the need for
re-positioning of the tube when the carina was not seen on
the monitor's screen. After completion of the surgery and
extubation, all patients were transferred to the post-
anesthesia care unit (PACU), where they were monitored
for one hour. Heart rate, respiratory rate, non-invasive
blood pressure and oxygen saturation were continuously
monitored in PACU, and recorded once in every 5 minutes
by the nurses. A face mask with oxygen (10 L/min) was
used in all patients. Oxygen saturation of 90% or lower, re-
spiratory rate above 20/min, breathing exertion, and
patient's complaint of breathing difficulty were all reportedby the nurse to the attending PACU physician and man-
aged immediately as required.
In each patient, the following variables that were re-
corded during the pre-operative examination: age, sex,
body weight, body mass index (BMI), ASA class, and
various parameters of airway assessment: the extent of
mouth opening and temporomandibular joint move-
ment, the state of their dentition, the thyro-mental dis-
tance, the presence of micrognatia and a short thick
neck, and the Mallampati score [17]. The following
intra-operative variables were recorded by the attending
anesthesiologist: the duration of intubation (from intro-
ducing the laryngoscope into the mouth until the tube’s
cuff is inflated), direct laryngoscopic view according to
the Cormack - Lehane classification [18], the number of
intubation attempts until successful intubation was accom-
plished, and the number of times that the laryngoscope
blade needed replacing. The following post-operative con-
sequences were recorded by a PACU nurse, who was
blinded to the study group: laryngospasm, stridor, hoarse-
ness, sore throat, tooth damage and soft tissue injury, such
as a bleeding lip or injured gums.Data analysis
A commercial statistical software package (Statistica 6.0,
StatSoft, Tulsa OK, USA) was used to analyze the data.
Pearson’s chi square test was used to compare frequen-
cies. Continuous variables were compared using analysis
of variance. Whenever the homogeneity of variance was
violated according to the results of the Levene’s test, the
Mann–Whitney test was used. Data are displayed at
mean ± standard deviation (SD) and statistical signifi-
cance was set at 5%.Results
All study patients in the two groups were successfully
intubated. No patient was excluded from the study be-
cause of difficult mask ventilation or other reason.
Regarding the pre-operative characteristics and airway
assessment of the patients, we found that the studied
groups were similar in terms of their demographics and
ASA physical status (Table 1). The Mallampati scores
were significantly higher in the test group than in the
control group (p = 0.01).
Endotracheal intubation was significantly longer in the
test group. It took 29 ± 10 and 24 ± 8 seconds using the
VivaSight™ SL and the conventional endotracheal tube re-
spectively (p = 0.02). However, patients in the control
group had significantly more soft tissue damage than
those in the test group (p < 0.05) when examined in the
PACU. No statistically significant differences in the other
study parameters of the two groups were found (Table 2).
Table 1 The preoperative characteristics and airway






(N = 40) (N = 32)
Age, years 43.1 (±4.9) 42.5 (±3.2) NS
Male/Female 14/26 9/23 NS
Weight, kg 128 ± 26 124 ± 27 NS
BMI 44.8 ± 7.5 43 ± 6.8 NS
ASA physical status class I/II/III 17/22/1 12/18/2 NS
Airway assessment







TMJ movement: normal/limited 35/5 31/1 NS
Neck: normal/short 37/3 32 NS
Mallampati score: 1/2/3/4 4/21/14/1 13/14/5/0 P = 0.01
Notes:
Data are displaced at mean ± standard deviation (SD).
NS = not significant.
BMI = body mass index.
ASA = American Society of Anesthesiologists.
TMJ = temporo-mandibular joint.







(N = 40) (N = 32)
Endotracheal intubation
Duration (seconds) 29 ± 10 24 ± 8 P = 0.02
Grades of the direct
laryngoscopic view








Laryngospasm 0 0 NS
Hoarseness 0 0 NS
Stridor 0 0 NS
Sore throat 2 3 NS
Soft tissue injury 0 3 P < 0.05
Tooth damage 0 0 NS
Notes:
Data are displaced at mean ± standard deviation (SD).
NS = not significant.
*Grades of the direct laryngoscopic views according to the Cormack-Lehane
classification [18].
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In this study the use of VivaSight™ ETT was compared to
the use of conventional ETT in morbidly obese patients.
The patients in the test group had a higher Mallampati
score distribution than those who were in the control
group. Endotracheal intubation using the VivaSight™ ETT
took significantly longer than that using a conventional
ETT and was less injurious. No significant difference in all
other variables was found in the two study groups.
Endotracheal intubation is an essential tool in man-
aging the patient under general anesthesia, yet it may re-
sult in airways damage. Injuries, usually of minor degree,
of the gums, pharynx and larynx, oedema of the larynx,
vocal cord injury, sore throat and more significant com-
plications as tracheal tear, may all be the sequelae of
traumatic laryngoscopy and intubation [19,20]. Morbi-
dely obese patients are at higher risk of these complica-
tions [5,6,21]. While the technique and device that are
used during intubation of the obese patient may affect
the outcomes, the superiority of a one method over any
other in terms of safety or effectiveness is yet to be de-
termined [21].
One of the limitations of this investigation is the sig-
nificant difference in the Mallampati score distribution
of study groups. Since the patients in the test group had
a higher Mallampati score than those in the control
group one could assume that they were in higher risk
for difficult intubation [17]. This increased risk is par-
tially offset by the similarity in the grades of direct laryn-
goscopic views in the two groups because this grade is
more indicative of intubation difficulty than the Mallam-
pati score. A second limitation of the study is that the
ETT position in the control group was not determined
with fiberoptic bronchoscopy. Thus we cannot comment
about its position and any tube displacement during the
surgery. Finally, the size of the study's cohort. It is esti-
mated that difficult direct laryngoscopy occurs in 1.5-
8.5% of all general anesthesias and failed intubation occurs
in 0.13-0.3% of all general anesthesias [22]. Therefore, in
order to obtain significant results in a prospective study
whose aim is to evaluate a new device for difficult intuba-
tions hundreds of patients are required.
Continuous visual surveillance of ETT position in pa-
tients while undergoing bariatric surgery is beneficial for
the anesthesiologist and for the patient's safety. While
placing the patient in the operating position for laparo-
scopic sleeve gastrectomy, the ETT may become dis-
placed and its tip might move distally or closer to the
carina due to peritoneal inflation [15,16,23,24] and result
in ventilation of only one lung. Insertion of an esopha-
geal bougie may also cause tube displacement. Verifying
the ETT placement and position in the obese patient
using auscultation may be difficult because the breath
sounds are quiet and distant. Finally, the working
Barak et al. BMC Anesthesiology 2014, 14:31 Page 5 of 6
http://www.biomedcentral.com/1471-2253/14/31conditions in bariatric laparoscopic surgery, namely a
dark or poorly-lit room in which the patient is fully cov-
ered and the operating table is elevated, make it very dif-
ficult for the anesthesiologist to ensure the ETT is in
place or to safely change its location when the ETT be-
comes displaced. Accordingly, visualization of the carina
on the VivaSight™ monitor has a reassuring effect on the
attending anesthesiologist, and once the ETT is dis-
placed, it can be re-positioned before hypoxemia ensues.
During difficult intubations, when the laryngoscopic
view is poor, the use of VivaSight™ SL may be advanta-
geous. When the laryngoscopic view is good, during dir-
ect laryngoscopy, the anesthesiologist can use the device
as a standard ETT. When the laryngoscopic view is poor,
the anesthesiologist can be assisted by the view on the
monitor's screen to direct the ETT into the vocal cords.
The anesthesiologist does not have to change equipment
or position or repeat the direct laryngoscopy. In addition,
no time is lost and no injury to the patient's larynx is
caused by a repeated laryngoscopy.
Determining the cost-effectiveness of new equipment
is difficult. Picot et al. [25] did an economic evaluation
of bariatric surgery and found that the surgical manage-
ment of obesity (BMI ≥30) was more expensive than
non-surgical management in the immediate short-
term, but was significantly cost-effective two to 20 years
after the surgery. Similar findings were also reported
by Sussenbach et al. [26] when they compared the dir-
ect and indirect costs of obesity and related co-
morbidities. Sussenbach et al. also reported that the
cost of the bariatric surgery is high, but the expenses
for medications, professional care, and examinations
decrease progressively after the surgery [26]. The cost
of one disposable VivaSight™ SL ETT is currently about
€100 and the monitor, which can be used repeatedly, is
€750. Accordingly, their purchase and use increase the
cost of the procedure, this should be considered in the
light of its possible benefits.Conclusions
In this study we found the VivaSight™ SL ETT to be an
interesting addition to the armamentarium of airways
devices. Intubation with this device took longer and was
less injurious than with the conventional ETT in groups
of obese patients that differ in their Mallampati scores
distribution. Its benefits in the management of the pa-
tient with difficult airway are yet to be tested.
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